Ankylosing Spondylitis and Its Impact on Immunity - Internal Medicine

Share to:

Ankylosing spondylitis and immunity?


Hello Doctor, I am currently 18.7 years old.
I have already received the first dose of the BNT vaccine and am considering self-paying for the first dose of a biologic agent and the second dose of the BNT vaccine.
I would like to ask you: 1) How long before receiving the first dose of the biologic agent should I ideally get the second vaccine dose? If I have already received the first dose of the biologic agent, how long should I wait before getting the COVID-19 vaccine? 2) Previously, while on medication, my inflammatory markers were controlled at CRP 0.3 and ESR 14.
Recently, while on the same medication, my markers have risen to CRP 0.9 and ESR 40.
Aside from the suspicion that it may be caused by the COVID-19 vaccine, could it be possible that my immune system has strengthened (as I am becoming more of an adult), leading to an increase in autoimmune activity and making it harder to control my inflammatory markers? 3) Generally speaking, at what age does immune function peak? Is it possible that after reaching that age, my immune function gradually weakens, leading to a gradual reduction in stiffness symptoms? 4) I would like to ask you a conceptual question.
Stiffness is an autoimmune issue, and it is also said to be caused by an overactive immune system (I am not sure if this is correct).
I want to ask you, if I focus on maintaining good health (going to bed early, waking up early, eating more fruits and vegetables, etc.), strengthening my body and boosting my immune system, could this actually worsen my stiffness?

Yong, 10~19 year old female. Ask Date: 2022/02/16

Dr. Zeng Guosen reply Internal Medicine


1) Some biologic agents have effects, while others do not; please consult the attending physician.
2) Autoimmune diseases can have fluctuating conditions, and vaccines may also have an impact, so it is important to consider the actual situation.
3) Generally, in ankylosing spondylitis, inflammation and disease activity may improve after the age of 50, but this varies from person to person.
4) It is good to pay attention to health maintenance, but there is no need to deliberately take immune-boosting medications or foods.
Thank you.

Reply Date: 2022/02/16

More Info


Ankylosing Spondylitis (AS) is a type of inflammatory arthritis that primarily affects the spine and the sacroiliac joints in the pelvis. It is characterized by chronic inflammation, which can lead to pain and stiffness in the back and hips. Understanding the relationship between AS, immunity, and vaccination is crucial for managing the condition effectively.

1. Timing of Vaccination with Biological Agents: When considering the administration of COVID-19 vaccines (like the BNT vaccine) in conjunction with biological treatments for AS, it is generally recommended to space out the timing of these interventions. The ideal scenario is to receive the vaccine at least two weeks before starting a biological agent. This allows your immune system to mount a response to the vaccine without interference from the immunosuppressive effects of the biological treatment. If you have already started the biological treatment, it is advisable to consult your healthcare provider about the appropriate waiting period before receiving the vaccine. Typically, a gap of at least several weeks is suggested, but this can vary based on the specific biological agent used.

2. Inflammatory Markers and Immunity: The increase in your inflammatory markers (CRP and ESR) despite ongoing treatment could be multifactorial. While it is possible that the recent vaccination could have triggered a temporary inflammatory response, it is also plausible that your immune system is adjusting as you transition into adulthood. As individuals mature, their immune systems can undergo changes that might affect autoimmune conditions. However, it is essential to consider other factors such as stress, infections, or changes in medication adherence that could also contribute to elevated inflammatory markers. Regular monitoring and communication with your healthcare provider are vital to understanding these fluctuations.

3. Peak Immunity and Age: Generally, the immune system reaches its peak function in early adulthood, around the ages of 20 to 30. After this peak, there is a gradual decline in immune function, which can lead to a decrease in the severity of autoimmune conditions like AS. However, this is not a universal rule, and individual experiences can vary significantly. Some patients may find that their symptoms improve with age, while others may continue to experience significant challenges. It is essential to maintain a healthy lifestyle, including regular exercise and a balanced diet, to support overall health and potentially mitigate symptoms.

4. Autoimmunity and Lifestyle: AS is indeed considered an autoimmune condition, where the immune system mistakenly attacks the body's own tissues. The notion that a stronger immune system could exacerbate autoimmune conditions is valid. While maintaining a healthy lifestyle is crucial, it is essential to strike a balance. Overstimulation of the immune system through excessive exercise or certain dietary choices could potentially lead to increased inflammation. Therefore, it is advisable to focus on a holistic approach that includes moderate exercise, stress management, and a balanced diet rich in anti-inflammatory foods.

In conclusion, managing Ankylosing Spondylitis requires a comprehensive understanding of the interplay between the immune system, treatment regimens, and lifestyle choices. Regular consultations with healthcare professionals, including rheumatologists and immunologists, are essential to tailor a treatment plan that addresses your specific needs. Additionally, staying informed about the latest research and recommendations regarding vaccinations and biological treatments will empower you to make informed decisions about your health.

Similar Q&A

Managing Ankylosing Spondylitis: Medication, Exercise, and Inflammation Concerns

Hello Doctor: I am a patient with ankylosing spondylitis. 1) I have been taking Secukinumab for six months, and it has been effective in controlling my condition. However, recently, despite unchanged medication, my pain and inflammation levels have increased. I would like to ask ...


Dr. Zeng Guosen reply Internal Medicine
Hello, online friend. 1) Autoimmune diseases have a characteristic of fluctuating symptoms, which may not always be related to medication issues. 2) Vaccines can activate autoimmune diseases or trigger immune abnormalities in approximately 5%-10% of cases. 3) The impact of food i...

[Read More] Managing Ankylosing Spondylitis: Medication, Exercise, and Inflammation Concerns


Understanding Ankylosing Spondylitis: Diagnosis and Waiting Times

I would like to ask, because my friend previously had this examination at Taipei Hospital, and the hospital said that the testing needs to be outsourced, but we still haven't received the results. I would like to know approximately how long it will take to receive them, and ...


Dr. Chen Xingyuan reply Orthopedics
Dear Maruko, Ankylosing Spondylitis (AS) is an autoimmune disease primarily affecting the joints and surrounding tissues, particularly the spinal joints. It commonly occurs in patients aged 20 to 40 years. Patients often experience lower back pain, spinal stiffness, and limited ...

[Read More] Understanding Ankylosing Spondylitis: Diagnosis and Waiting Times


Understanding ESR and IgG Fluctuations in Ankylosing Spondylitis Treatment

Hello, I would like to ask about a personal case of ankylosing spondylitis. I was diagnosed at the age of 10, and I am now 28 years old. I have been taking Celebrex and Methotrexate. In 2023, I applied for biologic therapy at Mackay Memorial Hospital and started receiving Remicad...


Dr. Gao Jiankai reply Internal Medicine
Hello, thank you for your question. The reasons for the increase in ESR and IgG after administering targeted therapy should be investigated, including the possibility of new inflammation or infection, or even changes in rheumatic disease. These factors involve the overall conditi...

[Read More] Understanding ESR and IgG Fluctuations in Ankylosing Spondylitis Treatment


Does Ankylosing Spondylitis Increase Risk of Low White or Red Blood Cells?

Hello, Doctor Gao. I am a 20-year-old patient with ankylosing spondylitis, diagnosed 3.5 years ago and currently undergoing stable treatment. I would like to ask you, excluding the effects of medications used in treatment, does ankylosing spondylitis itself predispose patients to...


Dr. Gao Jiankai reply Internal Medicine
Hello, thank you for your question. Ankylosing spondylitis does not cause leukopenia; however, untreated long-term ankylosing spondylitis may lead to mild anemia due to chronic inflammation suppressing bone marrow hematopoiesis. Additionally, if severe pain or poor control necess...

[Read More] Does Ankylosing Spondylitis Increase Risk of Low White or Red Blood Cells?


Related FAQ

Ankylosing Spondylitis

(Internal Medicine)

Autoimmune Disease

(Internal Medicine)

Ankylosing Spondylitis

(Orthopedics)

Arthritis

(Internal Medicine)

Immune System

(Internal Medicine)

Vasculitis

(Internal Medicine)

Vaccination

(Internal Medicine)

Antinuclear Antibody

(Internal Medicine)

Allergic Rhinitis

(Internal Medicine)

Std Infection

(Internal Medicine)